Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive ...
Becton, Dickinson and Co. (BD) has appointed longtime Edwards Lifesciences sales and marketing exec Tim Patz as the new ...
Sigma Planning Corp reduced its stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange ...
An Avon man has been found guilty by a Madison Circuit Court Division 6 jury of possession of methamphetamine. The jury returned the guilty verdict Wednesday against Jeffrey Lynn Edwards, 33, ...
Embodied carbon reduction strategies helped guide the design of Edwards Lifesciences’ Mussallem Innovation Center, a mix of ...
This was the stock's third consecutive day of losses.
Zovighian said the transition to CEO has been relatively smooth since he joined Edwards in 2015 and spent eight years in ...
Edwards Lifesciences Corp. closed 23.74% short of its 52-week high of $96.12, which the company achieved on March 28th.
A federal court granted summary judgment to Edwards Lifesciences LLC on a Title VII failure to accommodate religious observance claim of a senior cardiovascular specialist who alleged that Edwards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results